Vertaling van "pharmacological action " (Engels → Nederlands) :

pharmacologic action | pharmacological action

pharmacologic action | pharmacological action

residue levels for pharmacologically active substances | residues of substances having a pharmacological action

lead a clinical pharmacological study | lead clinical study on drug action | lead a clinical pharmacology study | lead clinical pharmacology studies

science of pharmacology | study of pharmacology | pharmacology | study of drug action

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and ...[+++]psychological symptoms, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

pharmacology analyst | pharmacology studies researcher | pharmacologist | pharmacology studies research analyst

An adverse effect of a food that is not due to an immunologic abnormality but rather to metabolic, toxic, pharmacologic or unknown processes. Joint AAAAI/ACAAI practice parameters-Food intolerance 2014.

Definition: Personality disorder characterized by excessive sensitivity to setbacks, unforgiveness of insults; suspiciousness and a tendency to distort experience by misconstruing the neutral or friendly actions of others as hostile or contemptuous; recurrent suspicions, without justification, regarding the sexual fidelity of the spouse or sexual partner; and a combative and tenacious sense of personal rights. There may be excessive self-importance, and there is often excessive self-reference. | Personality (disorder):expansive paranoid | fanatic | querulant | paranoid | sensitive paranoid

Definition: This category includes certain disorders of behaviour that are not classifiable under other categories. They are characterized by repeated acts that have no clear rational motivation, cannot be controlled, and generally harm the patient's own interests and those of other people. The patient reports that the behaviour is associated with impulses to action. The cause of these disorders is not understood and they are grouped together because of broad descriptive similarities, not because they are known to share any other important features.

A herbal product will be considered a medicinal product where presented as having properties for treating or preventing disease in human beings or where it has a pharmacological, immunological or metabolic action.

(b) Any substance or combination of substances which may be used in human beings either with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions by exerting a pharmacological action.

Any substance or combination of substances which may be used in human beings either with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions by exerting a pharmacological action.

Medical devices and their accessories as covered by Directives 90/385/EEC*, 93/42/EEC** and 98/79/EC*** on condition that such devices and accessories do not exert a pharmacological action .